共 170 条
- [31] Kommoss F(2019)Congruence between 1994 who classification of endometrial hyperplasia and endometrial intraepithelial neoplasia system Am J Clin Pathol 25 61-702
- [32] Travaglino A(2019)Endometrial hyperplasia and risk of coexistent cancer: WHO vs EIN criteria Histopathology 9 405-445
- [33] Raffone A(2019)Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment Gynecol Endocrinol 25 696-1398
- [34] Saccone G(2019)Treatments and overall survival in patients with Krukenberg tumor Arch Gynecol Obstet 47 439-1128
- [35] Kim G(2019)Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer APMIS 29 1390-83
- [36] Kurnit KC(2019)Clear cell endometrial carcinoma and the TCGA classification Histopathology 41 1121-75
- [37] Djordjevic B(2019)Accuracy of one-step nucleic acid amplification in detecting lymph node metastases in endometrial cancer Pathol Oncol Res 42 76-5947
- [38] Raffone A(2019)Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy APMIS 151 69-844
- [39] Travaglino A(2019)Significant risk of occult cancer in complex non-atypical endometrial hyperplasia Arch Gynecol Obstet 24 5939-S63
- [40] Saccone G(2019)TCGA molecular groups of endometrial cancer: pooled data about prognosis Gynecol Oncol 28 836-S113